Drug Safety and Risk Management Advisory Committee; Amendment of Notice

---
identifier: "/us/fr/05-9228"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Drug Safety and Risk Management Advisory Committee; Amendment of Notice"
title_number: 0
title_name: "Federal Register"
section_number: "05-9228"
section_name: "Drug Safety and Risk Management Advisory Committee; Amendment of Notice"
positive_law: false
currency: "2005-05-09"
last_updated: "2005-05-09"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "05-9228"
document_type: "notice"
publication_date: "2005-05-09"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "70 FR 24449"
fr_volume: 70
fr_action: "Notice."
---


#  Drug Safety and Risk Management Advisory Committee; Amendment of Notice

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Drug Safety and Risk Management Advisory Committee. This meeting was announced in the *Federal Register* of April 14, 2005 (70 FR 19763). The amendment is being made to reflect a change in the *Date and Time* portion of the document. The start time for each day of the meeting will be changed. There are no other changes.

**FOR FURTHER INFORMATION CONTACT:**

Shalini Jain, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington DC area), code 3014512535. Please call the Information Line for up-to-date information on this meeting.

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of April 14, 2005, FDA announced that a meeting of the Drug Safety and Risk Management Advisory Committee would be held on May 18 and 19, 2005, from 8:30 a.m. to 5 p.m. On page 19763, in the third column, the *Date and Time* portion of the meeting notice is amended to read as follows:

*Date and Time* : The meeting will be held on May 18 and 19, 2005, from 8 a.m. to 5 p.m.

This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

Dated: May 3, 2005.

Lester M. Crawford,

Acting Commissioner of Food and Drugs.